Kirloskar Brothers Q2 FY27: revenue up 24% YoY, but margin compression caps PAT growth

Kirloskar Brothers' consolidated Q2 FY27 revenue rose 24.2% YoY (and 15.5% QoQ) to ₹1,276.7 Cr, landing at the top of our pre-result preview's ₹1,250–1,280 Cr range and confirming management's FY27 guidance of double-digit growth — a line that gets a clear beat this quarter after Q1's foundry-modernisation-led dispatch delays. Consolidated PAT came in at ₹74.7 Cr, within the preview's ₹65–75 Cr band, but its growth rate — +3.5% YoY reported, ~+7.6% YoY adjusted for a ₹2.8 Cr one-off gain in the year-ago quarter (reversal of a KPML sales-tax provision) — trails revenue growth by a wide margin. Basic EPS was ₹9.28 against ₹8.94 a year ago and ₹8.39 last quarter. The gap is a margin story, not a demand one. Operating margin (EBITDA/revenue) compressed to 9.74% from 10.82% YoY and 10.48% QoQ, and net margin fell to 5.77% from 6.92% YoY. The driver sits on the cost-of-materials line: materials consumed rose to 52.5% of revenue from 47.0% a year ago, outpacing 24% topline growth, even as employee costs fell as a share of revenue (16.6% vs 18.2% YoY) on operating leverage. A ₹0.5 Cr loss from the joint venture — versus a ₹4.8 Cr profit contribution a year ago — added a further ~₹5.3 Cr drag. This is precisely the margin-recovery question our pre-result preview flagged as the real test of the quarter, and it was not resolved — margins compressed further rather than recovering. Standalone tells a different story that readers will see elsewhere: standalone PAT of ₹54.4 Cr is up 44.7% YoY, but that growth is almost entirely a one-off — the standalone statement discloses a ₹56.4 Cr write-back of old trade-receivable provisions booked under 'Other Expenses' this quarter, which the company explicitly states 'does not have any impact on the Company's consolidated financial results.' Strip that out and underlying standalone profitability was down sharply YoY, consistent with the consolidated margin-compression picture. International revenue grew 25.3% YoY to ₹463.3 Cr, roughly in line with 24.0% YoY growth from domestic operations (₹813.4 Cr), but international came in modestly below the preview's ₹475–500 Cr expectation. Corporate developments this quarter were largely administrative rather than financial — the statutory auditor converted to an LLP structure, the company received an ESG rating of 70 ('Aspiring'), and Dr. Madhuri Kanitkar was appointed an additional director — alongside an August Supreme Court order directing arbitration on a pending legal matter, whose financial impact is not quantified in this filing. No management press release or post-result commentary was available in our records at the time of this extraction, so framing rests on the filing and the prior concall guidance alone. Heading into Q3, the questions the company set for itself remain open: the FY27 double-digit growth trajectory is clearly on track (+24% YoY this quarter), but it has now been accompanied by two consecutive quarters of margin compression rather than the recovery flagged as the key watch item, and the joint venture remains a swing factor on the bottom line.